BCL6 has low activity in severe and moderate COVID-19 patients; its loss implies hyper-proliferation, followed by the expression of STAT3 to secrete IL-6, contributing to the cytokine storm in severe COVID-19 patients (87). This evidence concerns the gene BCL6 and COVID-19.